8th Bacteriophage Therapy Summit 2026 Novotel London West, London

This is the only industry-led, industry dedicated meeting, tackling the real-world challenges preventing bacteriophage therapies from reaching patients – from manufacturing and clinical trial design to investment models and evolving regulatory expectations. As regulators clarify approval pathways, phage’s make it into late-stage clinical trials, and investment momentum returns, 2026 marks a pivotal moment for the phage field to shift from promise to practical delivery.

If you are determined to ensure the community can bring precise, scalable and commercially viable products to market, this is your one-stop platform to make it happen.

Over three days, you will connect directly with C-level experts, decision-makers and leading minds across biotech, pharma, academia, policy and investment who are defining how phage-based products move through approval and adoption. Discover new data, actionable frameworks and the collaborations that will shape the next generation of antibacterial solutions.